No valuation for Gene Solutions (Laboratory Services (Healthcare)) is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($236.0M) and the funding record below are the closest available signals.
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Gene Solutions (Laboratory Services (Healthcare))
- ·The full record, as it builds
Funding history
No funding rounds for Gene Solutions (Laboratory Services (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Gene Solutions (Laboratory Services (Healthcare))'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Gene Solutions (Laboratory Services (Healthcare)), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Gene Solutions (Laboratory Services (Healthcare)) raised?
- Gene Solutions (Laboratory Services (Healthcare)) has raised $236.0M in total funding across its recorded rounds.